EMIR 3 Regulation and Directive Published

EMIR 3 Regulation strengthens EU clearing markets with active account requirements and risk management updates, reducing third-country CCP dependencies and enhancing financial stability.

EMIR 3 Regulation and Directive Published




On December 4, 2024, the European Union published the EMIR 3 Regulation and Directive in the Official Journal, marking a significant moment for financial market regulation. These updates include Regulation (EU) 2024/2987, which revises rules under the EMIR 3 regulation to reduce reliance on third-country central counterparties (CCPs) and improve the efficiency of EU clearing markets. Additionally, Directive (EU) 2024/2994 strengthens frameworks for managing concentration and counterparty risks in centrally cleared transactions. Together, these measures bolster the stability and competitiveness of the EU's financial ecosystem, ensuring transparency, risk mitigation, and supervisory harmonization.




Source

[1]

Regulation - EU - 2024/2987 - EN - EUR-Lex

[2]

Directive - EU - 2024/2994 - EN - EUR-Lex



EMIR 3 Regulatory Framework


A. Regulation (EU) 2024/2987: Transforming Clearing Practices and Risk Management


The EMIR 3 Regulation (EU) 2024/2987 is a critical component of the EU's broader regulatory overhaul, targeting the financial system's resilience and efficiency in light of evolving market dynamics. Published as part of the EMIR 3 package, this regulation introduces significant amendments to Regulation (EU) No 648/2012, with far-reaching implications for financial and non-financial market participants.




1. Key Points of Regulation (EU) 2024/2987


1.1. Active Account Requirements

One of the most transformative aspects of Regulation (EU) 2024/2987 is the active account requirement, designed to reduce reliance on third-country central counterparties (CCPs). Financial counterparties, non-financial counterparties, and clearing members engaging in derivative contracts deemed of substantial systemic importance must:


  • Open and maintain active accounts with EU-authorized CCPs.
  • Ensure that a representative number of transactions are cleared through these accounts, promoting local clearing market activity.
  • Report compliance with these requirements biannually to relevant supervisory authorities.

This requirement is particularly aimed at mitigating financial stability risks associated with Tier 2 third-country CCPs, such as those in the UK post-Brexit.


1.2. Strengthened Risk Management for Derivatives

The regulation revises clearing thresholds, ensuring entities exceeding these limits are subject to the clearing obligation. By recalibrating the thresholds, ESMA ensures comprehensive coverage of systemic risk. Furthermore, the regulation emphasizes the integration of post-trade risk reduction (PTRR) services, such as portfolio compression and rebalancing, which help institutions optimize derivative portfolios while adhering to clearing obligations.


1.3. Enhanced Transparency and Reporting

Regulation (EU) 2024/2987 introduces stricter requirements for data quality and transparency. Financial institutions must:


  • Report high-quality data on cleared and uncleared derivatives.
  • Demonstrate the integrity of their reporting mechanisms, including robust internal controls. This ensures that regulators receive consistent and accurate data for effective supervision.

1.4. Provisions for Third-Country CCPs

To address systemic dependencies, the regulation introduces measures that:


  • Mandate EU market participants to gradually reduce exposures to third-country Tier 2 CCPs.
  • Strengthen the recognition framework for third-country CCPs, requiring more detailed assessments of their risk management and operational structures. These changes aim to balance financial stability with the practical need for international clearing connectivity.

1.5. Streamlined Approval Processes for CCPs

The regulation simplifies processes for EU CCPs to introduce new services or expand existing ones. This includes an accelerated approval mechanism for non-material changes, allowing EU CCPs to respond swiftly to market demands without compromising safety.


2. Institutions Impacted by Regulation (EU) 2024/2987


2.1. Financial Counterparties

Banks, investment firms, and insurance companies are directly impacted as they often engage in derivative trading. These entities must comply with the active account requirements and revise their clearing strategies to prioritize EU-authorized CCPs.


2.2. Non-Financial Counterparties

Corporations with significant derivative exposures, such as energy firms and multinational enterprises, must:


  • Monitor their positions to avoid breaching recalibrated clearing thresholds.
  • Establish compliance mechanisms for reporting and managing derivatives cleared through EU CCPs.

2.3. Central Counterparties (CCPs)

EU CCPs benefit from increased volumes but face enhanced supervisory scrutiny. They must provide granular reporting on:


  • Clearing activities.
  • Risk management practices.
  • Liquidity reserves and stress-testing outcomes. Third-country CCPs face more stringent recognition standards, impacting their ability to serve EU participants.

3. Compliance Requirements for Institutions


To comply with Regulation (EU) 2024/2987, institutions must take proactive measures, including:


3.1. Active Account Setup

Entities subject to clearing obligations must:


  • Establish fully operational accounts at EU-authorized CCPs, including IT connectivity, legal documentation, and operational processes.
  • Ensure these accounts can handle large volumes of derivative transactions, even under stressed market conditions.

3.2. Adjusted Clearing Strategies

Institutions must evaluate their derivative portfolios to ensure compliance with active account obligations. This includes shifting trades from third-country CCPs to EU-authorized ones.


3.3. Strengthened Risk Management

Participants must:


  • Implement post-trade risk reduction services for efficient portfolio management.
  • Maintain robust internal controls to ensure data quality and compliance with reporting obligations.

3.4. Regulatory Engagement

Entities must actively collaborate with supervisory authorities, submitting detailed reports on clearing activities, account usage, and compliance with active account requirements.


EMIR 3: Concentration and Counterparty Risk Management


Directive (EU) 2024/2994 enhances risk management for concentration and counterparty risks, strengthens reporting, and aligns practices with updated regulatory standards. Its purpose is to safeguard financial stability and ensure consistent risk management across the EU financial system.


1. Key Points of Directive (EU) 2024/2994


1.1. Enhanced Concentration Risk Management

The directive emphasizes the need for institutions to monitor and mitigate concentration risks, especially exposures to Tier 2 CCPs deemed systemically important. Key measures include:


  • Regulatory Frameworks: Institutions must develop robust processes for identifying, measuring, and managing concentration risks.
  • Supervisory Oversight: Competent authorities are empowered to enforce stricter controls on institutions with excessive exposures to specific CCPs.
  • Pillar 2 Enhancements: Supervisory authorities can impose additional capital requirements or other measures for firms unable to adequately manage concentration risks.

1.2. Counterparty Risk Harmonization

The directive updates counterparty risk limits, ensuring consistency across all derivative transactions, whether centrally cleared or over-the-counter (OTC). Highlights include:


  • Uniform Risk Limits: Risk limits now apply uniformly to exchange-traded and OTC derivatives, fostering a level playing field.
  • Enhanced Clearing Obligations: Counterparty risk limits are adjusted to reflect the reduced risk associated with clearing through EU-authorized CCPs.

1.3. Reporting and Stress Testing

Institutions must implement enhanced reporting mechanisms for counterparty exposures. Supervisory stress testing is also mandated, focusing on the impact of Tier 2 CCP exposures under adverse conditions. Key requirements include:


  • Development of Targeted Risk Plans: Institutions must establish specific, measurable plans to address concentration risks.
  • Supervisory Assessments: Authorities will evaluate institutions' progress in adapting business models to comply with the directive.

1.4. Institutional Alignment

To align with the broader goals of EMIR 3 regulation, the directive requires institutions to harmonize their risk management practices with updated regulatory standards. This includes ensuring all derivative transactions cleared through Tier 2 CCPs are reassessed under the new framework.


2. Institutions Impacted by Directive (EU) 2024/2994


2.1. Credit Institutions

Banks and other credit institutions are directly affected due to their significant exposure to CCPs. These entities must revise risk management frameworks and comply with stricter capital and supervisory requirements.

2.2. Investment Firms

Firms operating under Directive 2013/36/EU and 2019/2034 face increased scrutiny. They must adjust risk management practices to meet enhanced concentration and counterparty risk guidelines.


2.3. Fund Managers

UCITS and Alternative Investment Fund Managers (AIFMs) are also impacted. These entities must ensure that their clearing practices for derivative transactions align with the new counterparty risk limits and reporting obligations.


3. Compliance Requirements for Institutions


To meet the requirements of Directive (EU) 2024/2994, institutions must undertake several key actions:


3.1. Develop Comprehensive Risk Management Plans

  • Institutions must craft detailed risk management plans addressing concentration risks to Tier 2 CCPs.
  • These plans must include quantifiable targets, actionable steps, and regular progress reviews.

3.2. Adjust Business Models
  • Firms with significant CCP exposures must realign their business models to mitigate concentration risks. This includes diversifying clearing arrangements and reducing reliance on specific Tier 2 CCPs.

3.3. Strengthen Reporting Systems
  • Enhanced reporting obligations require institutions to provide detailed data on counterparty exposures and compliance with risk limits. This includes stress-testing results and plans to address identified vulnerabilities.

3.4. Engage with Supervisory Authorities
  • Institutions must work closely with competent authorities to demonstrate adherence to the directive. This involves submitting risk management plans, compliance updates, and stress-testing results.

EMIR 3: Timeline of Implications
EMIR 3: Timeline of Implications


EMIR 3: Timeline of Implications


  • December 24, 2024: Regulation (EU) 2024/2987 enters into force. Most provisions become applicable immediately, though technical standards may delay certain aspects.
  • June 25, 2026: Member States must transpose Directive (EU) 2024/2994 into national law.
  • Post-2026: Regular evaluations by ESMA and other supervisory bodies will refine implementation and address emerging risks.



Future Regulatory Moves


  • Enhanced Monitoring: ESMA will likely intensify oversight of CCPs, focusing on systemic risks and compliance with active account requirements.
  • Global Collaboration: The EU may push for international harmonization, encouraging other jurisdictions to adopt similar standards.
  • Dynamic Adjustments: Future revisions to the EMIR framework could address emerging trends, such as the rise of digital assets and evolving derivative markets.



Strategic Impact of EMIR 3 Regulation and Directive


The EMIR 3 Regulation and Directive collectively reinforce the EU's commitment to financial stability and market efficiency. By reducing reliance on third-country CCPs and enhancing risk management practices, these updates safeguard the EU financial system against global uncertainties.


Institutions should not only aim for compliance but also strategically position themselves to leverage the regulatory shift. Adopting robust risk management frameworks, investing in compliance infrastructure, and fostering partnerships with EU-authorized CCPs can turn regulatory compliance into a competitive advantage.

Reduce your
compliance risks